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Abstract
Background: Ocimum gratissimum L. is a medicinal plant widely grown in tropical and subtropical regions with the
leaf decoction usually taken in folk medicine to enhance erectile performance in men although the probable
mechanism of actions remains undetermined. This study examined the inhibitory potentials of Ocimum gratissimum
leaves on some key enzymes associated with erectile dysfunction in penile and testicular tissues of the rat.
Methods: Inhibitory effect of aqueous extract (1:10w/v) of O. gratissimum leaves on the activities of phosphodiesterase-5
(PDE-5), arginase, angiotensin I –converting enzyme (ACE), and acetylcholinesterase (AChE) in penile and testicular tissues
were assessed. Also, the extract was investigated for ferric reducing antioxidant property(FRAP) and 1,1-diphenyl-2-picryl-
hydrazil (DPPH) radical scavenging abilities.
Results: The extract showed higher PDE-5 (IC50 = 43.19 μg/mL), ACE (IC50 = 44.23 μg/mL), AChE (IC50 = 55.51 μg/mL) and
arginase (IC50 = 46.12 μg/mL) inhibitory activity in the penile tissue than PDE-5 (IC50 = 44.67 μg/mL), ACE (IC50 = 53.99 μg/
mL), AChE (IC50 = 60.03 μg/mL) and arginase (IC50 = 49.12 μg/mL) inhibitory activity in the testicular tissue homogenate.
Furthermore, the extract scavenged free radicals and in a dose-dependent manner.
Conclusion: The enzyme activities displayed might be associated with the bioactive compounds present in the extract
which could possibly explain its use in the management of erectile dysfunction (ED).
Keywords: Erectile dysfunction, Angiotensin I –converting enzyme (ACE), Phosphodiesterase-5 (PDE-5),
Acetylcholinesterase (AChE), Arginase, Ocimum gratissimum
Background
The occurrence of erection involves the neuronal, vascu-
lar, endocrine and local secretory interplay. The pro-
cesses involved are blood vessel dilation, trabecular
smooth muscle relaxation, and activation of the
veno-occlusive mechanism of the corpus carvenosum
and spongiosum tissues [1]. Erectile dysfunction (ED) is
the inability to achieve and maintain penile tumescence
adequate for the suitable erotic act [2]. It occurs as a
result of the decrease in bioavailability of nitric oxide
(NO) due to decreased expression of endothelial tissue
nitric oxide synthase (NOS) activity and/or increased
elimination of NO [3]. However, NOS and arginase vie
for L-arginine as a substrate in cells. In the urea cycle,
L-arginine is converted to ornithine and urea and the
conversion is catalyzed by the enzyme arginase [4]. The
fast hydrolysis of secondary messengers such as cyclic
adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP) have been linked to pathologies
like ED [5]. Cyclic nucleotide phosphodiesterase (PDE)
enzymes regulate the cytosolic levels of secondary mes-
sengers [4, 6]. Predominantly in the smooth muscle of
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corpora cavernosum is phosphodiesterase type-5. Hence,
the mitigation of phosphodiesterase-5 (PDE-5) can also
be a therapeutic approach in the management of ED [6].
Additionally, acetylcholinesterase (AChE) inhibition is
an alternative technique for managing ED because it
controls the levels of acetylcholine [7]. Moreover, the in-
creasing AChE activity decreases the level of acetylcho-
line on conversion to its products acetate and choline [8,
9]. Earlier studies reported that inhibition of AChE can
increase the level of acetylcholine thereby improving
erection [10, 11]. Moreover, the renin–angiotensin sys-
tem (RAS) is also a key aspect in the development of
erectile dysfunction. Increase in the angiotensin-I con-
verting enzyme (ACE) caused by erectile dysfunction
simultaneously leads to the generation of angiotensin-II
[12–14]. Hence, ACE activity inhibition leads to an in-
crease in erectile performance and a significant reduc-
tion of angiotensin-II levels in patients with ED [15].
Oxidative stress-induced ED occurs when reactive oxy-
gen species such as superoxide anion (O2
−) reacting with
nitric oxide gas, forms peroxynitrite (ONOO2) and re-
duces the biological presence of NO [16]. Adequate in-
take of natural plant products may protect against
oxidative stress and reduce the chance of developing
several diseases like male sexual dysfunction [17]. Fur-
thermore, the management of ED with conventional
medicine is connected with adverse side effects and tox-
icities. Thus, the need to continuously explore medicinal
plants with sexual enhancing properties may serve as a
cheap and safe alternative therapy [18].
Ocimum gratissimum (OG) is a perennial herb that be-
longs to the family Lamiaceae. It is thought to originate
from Asia and Africa [19]. In Nigeria and other parts of
the world, it is used as a traditional vegetable condiment
and oral care products. Furthermore, OG had been shown
to possess numerous pharmacological properties hence its
use in traditional or alternative medicine. These properties
include antioxidant [20–24]; anti-anemic [25]; antidiar-
rhoeal [26] and protective effects on hepato-renal indices
[27]. In a study conducted by Iweala and Obidoa [29],
using Ocimum gratissimum-supplemented diet (OGSD),
rats fed with OGSD for 6 months showed an increased
number of spermatozoa suggesting the capacity of OG to
enhance reproductive ability [28]. Another study con-
ducted by Pande and Pathak [29] revealed that ethanolic
extract of OG, significantly increased the sexual behaviors
of normal male albino mice at a dose of 100, 250, and 500
mg/kg body weight for 7 days with 500mg/kg having the
most noticeable effect, without any gastric ulceration and
adverse effects [29, 30]. In addition to this, Ebong et al.
[31] reported that combined extracts of Moringa oleifera
and Ocimum gratissimum had better ameliorative effects
on testicular architecture and spermatogenesis after 28
days of treatment than Moringa extract alone in diabetic
rats. According to the authors, a combination of the two
plant extracts thus provides a cheap alternative to treating
diabetes-associated testicular damage and sexual dysfunc-
tion [31]. The plant leaf extract is used in alternative
medicine for the management of erectile dysfunction [31].
However, there is limited information on the possible
mechanisms of actions of O. gratissimum on the penile
and testicular function. Thus, this study investigated the
inhibitory effects of aqueous extract from O. gratissimum
leaves on enzymes such as (phosphodiesterase-5 (PDE-5),
angiotensin-1 converting enzyme (ACE), acetylcholin-
esterase (AChE), and arginase) relevant to ED in penile
and testicular tissue homogenates. Antioxidant activity
(ferric reducing antioxidant property (FRAP) and
1,1-diphenyl-2-picryl-hydrazil (DPPH)) of the leaves were
also examined.
Methods
Plant collection
O. gratissimum leaves were bought from a King’s market,
Ado-Ekiti in November 2017. It was authenticated by
Mr. Omotayo with herbarium number (UHAE 15) and
deposited at the Department of Plant Science, Ekiti State
University, Ado-Ekiti, Nigeria. The Ocimum gratissimum
leaves were dried and pulverized using a blender. The
powder obtained weighing 70 g was macerated in 700
mL of distilled water for 24 h at room temperature as
described by [32]. It was then filtered and the resulting
filtrate was concentrated on a steam bath to give a yield
of 40.45 g of the residue.
Chemicals and reagents
Chemicals such as acetylthiocholine iodide, 5,5′-dithio-bis
(2- nitrobenzoic acid) (DTNB), thiobarbituric acid (TBA),
trichloroacetic acid (TCA), and 1,1-diphenyl-2 picrylhy-
drazyl (DPPH) were sourced from Sigma-Aldrich, Chemie
GmbH (Steinheim, Germany). Acetic acid was procured
from BDH Chemical Ltd., (Poole, England). A Jenway
UV-visible spectrophotometer (Model 6305; Jenway, Barlo
World Scientific, Dunmow, United Kingdom) was used to
measure absorbance.
Handling of experimental animals
Twenty adult male Wistar albino rats (weighing between
290 ± 5 g) of about 10–14 weeks old were obtained from
Animal breeding house of Afe Babalola University and five
[5] rats were used for each of the assays carried out. They
were handled in accordance with the guide for Care and
Use of Laboratory Animals formulated by the National
Academy of Science, issued by the National Institute of
Health (USA). The ethical guidelines were followed in ac-
cordance with National and Institutional guidelines for
the protection of animal welfare during the experiments.
The study was approved by Afe Babalola University ethical
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review committee (ABUERC) with reference number 17/
ABUAD/066. The rats were allowed to acclimatize for 2
weeks and maintained at room temperature under labora-
tory conditions (12 h light/dark cycle) with access to rat
chow and water ad libitum.
Preparation of penile and testicular tissue homogenate
Experiment animals were placed under ether anesthesia
and euthanized by cervical dislocation, then tissue sam-
ples were collected. Penis and testes were removed,
washed, bottled dry and weighed. These tissues were ho-
mogenized in cold saline (1/10w/v) at approximately
1200 rpm in a homogenizer for 10 min at 3000 rpm. The
supernatant was collected and used for the inhibitory
enzyme activity assay.
Phosphodiesterase-5 (PDE-5) inhibitory activity
The ability of the extracts to inhibit PDE-5 activity was
evaluated by [33]. The assay solution containing 5 mM
of the substrate (p-nitrophenyl phenyl phosphonate),
100 μl of tissue (penile and testicular) supernatant, 20
mM Tris-HCL (pH 8.0) and the aqueous extracts of O.
gratissimum (20–100 μg/ml) were incubated at 37 °C for
10 min. The amount of p-nitrophenol produced was read
as a change in absorbance after 5 min at 400 nm. The
control experiment was performed without the extracts
and sildenafil. PDE-5 inhibitory enzyme activity was
expressed as percentage inhibition:
PDE  5 inhibition %ð Þ ¼ Abscontrol  Abssamples
 
=Abscontrol
  100
ð1Þ
where Abs control is the absorbance without the extract
and Abs samples are the absorbance with extract.
Arginase inhibitory activity
The penis and testicular homogenates were prepared by
homogenizing 10 g (w/v) of penile and testicular tissue
in cold buffer (phosphate buffer, pH 7.2). The homoge-
nized tissue samples were centrifuged for 20 min at
4000 rpm and the supernatant was used as the source of
enzyme. The activity of arginase was estimated by the
amount of urea produced via Ehrlich’s reagent. The solu-
tion comprised in final volume 1.0 mM Tris-HCl buffer
pH 9.5, 1.0 mM MnCl, 0.1M arginine solution, an aque-
ous extract of O. gratissimum (20–100 μg/ml) /L-2-ami-
no-[4-(20-hydroxyguanidino)] butyric acid (LNOHA)
which was made up to 1.0 mL. The solution was incu-
bated for 10 min at 37 °C and stopped by adding 2.5 mL
Ehrlich reagent (2.0 g of p-dimethyl amino benzaldehyde
in 20mL of concentrated hydrochloric acid and made
up to 100mL with distilled water). Absorbance was read
after 20 min at 450 nm. The control experiment was
performed without the test sample or standard and
arginase inhibitory activity was calculated as percent-
age inhibition [34].
Acetylcholinesterase activity assay
Penile and testicular tissue samples were homogenized
in cold phosphate buffer 0.1M, pH 7.2 and were used as
the source of AChE enzyme. The inhibitory effect of the
aqueous extracts of O. gratissmum (20–100 μg/ml) and
standard drug prostigmine on AChE activity was evalu-
ated as described by [8] with slight modifications. AChE
activity was estimated in a solution containing 200 μL
tissue homogenate, 100 μL of 5,5-dithiol-bis (2-nitro-
benzoic) acid (DTNB 3.3 mM, in 0.1 M phosphate
buffered solution, pH 7.0, containing 6 mM NaHCO3),
aqueous extracts of O. gratissmum. This was incu-
bated for 20 min at 25 °C, and acetylthiocholine iodide
was added. The absorbance of the enzyme activity
was read at 412 nm. AChE activity was expressed as
percentage inhibition [1].
Angiotensin-I-converting enzyme (ACE) inhibitory activity
Inhibition of the ACE activity of aqueous extracts of O.
gratissmum was determined according to the described
protocol of [35]. Varying concentrations of the aqueous
extract (20–100 μg/ml) and standard drug lisinopril and
50 μL of homogenate from penile and testicular tissues
as a source of ACE enzyme (4 mU/mL) were
pre-incubated at 37 °C for 15 min. Thereafter, the en-
zymatic process was started by adding 200 μL of 8.33
mM ACE substrate [hippuryl-l-histidyl-l-leucine (HHL)]
in 125 mM of Tris-HCl buffer (pH 8.3) to the solution
and incubated at 37 °C for 30 min. The reaction was ter-
minated by adding 300 μL of 1M HCl. The hippuric
acid (Bz-Gly) generated by the reaction was removed
with 2 mL ethyl acetate and further centrifuged to separ-
ate the ethyl acetate layer, it was later transferred to a
volumetric flask and evaporated to dryness. The ob-
tained residue was reconstituted in distilled water and
its absorbance was read at 228 nm. The control experi-
ment was done without the aqueous extract or standard
drug lisinopril. ACE percentage inhibition was then cal-
culated in Eq. (1).
Determination of antioxidant activities
Ferric reducing antioxidant ability
Reducing power of the aqueous extract was evaluated
via reduction of the FeCl3 solution by [36]. 3 mL of the
extract (20–100 μg/ml) was added to 3mL of 200 mM
sodium phosphate buffer (pH 6.6) and 3mL of 1% potas-
sium ferricyanide. The solution was incubated for 20
min at 50 °C in a water bath and 3mL of 10%
trichloroacetic acid was used to stop the reaction. The
sample was then centrifuged at 650 g for 10 min and 5
mL of the supernatant was added to an equal volume of
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water and 1.0 mL, 0.1% FeCl3. Absorbance was read at
700 nm. Vitamin C was used as the standard for asses-
sing reducing power and expressed as percentage
inhibition.
Free radical scavenging ability
Free radical scavenging ability of the aqueous extract
against DPPH. was assessed using the method of [37].
Concisely, suitable dilution of the aqueous extract (20–
100 μg/ml) was added to 1mL 0.4 mM DPPH solution
in methanol. The solution was kept in the dark for 30
min and the absorbance was read at 516 nm. DPPH*
scavenging ability was estimated with reference to the
control and the standard drug used for assessing DPPH
activity was vitamin C.
DPPHscavenging ability %ð Þ
¼ Abscontrol  Abssamples
 
=Abscontrol
  100
Data analysis
Data generated were analyzed by one-way analysis of
variance (SPSS, Version 20.0, IBM Corporation, NY,
USA) one-way ANOVA using Duncan multiple range
posthoc test (DMRT). Results are presented as the mean
± SD in triplicates (n = 3). Values were considered to be
significantly different at p < 0.05.
Results
Phosphodiesterase-5 activities (PDE-5) of aqueous ex-
tract of O. gratissmum in penile and testicular tissue ho-
mogenates were evaluated and presented in Fig. 1. The
result showed that the aqueous extract of O. gratiss-
mum inhibited PDE-5 enzymes. Taking into consider-
ation the IC50 (lower IC50 value means stronger
enzyme inhibition) presented in Table 1, it showed
that the extract had a greater inhibitory activity on
penile phosphodiesterase-5 (IC50 = 43.19 μg/mL) than
testicular phosphodiesterase-5 (IC50 = 44.67 μg/mL).
Though, sildenafil had the highest activity as shown
by the IC50 (26.65 μg/mL).
Arginase inhibitory activity by the aqueous extract of
O. gratissmum is displayed in Fig. 2. The extract inhib-
ited arginase activity in a concentration-dependent man-
ner. Though, the IC50 in Table 1 showed that the
aqueous extract of O. gratissmum had a greater inhibi-
tory activity on penile arginase (46.12 μg/mL) than tes-
ticular arginase (49.12 μg/ mL). Though, L-NOHA had
the highest inhibitory activity as shown by the IC50
(42.48 μg/mL).
Figure 3 showed the result of the inhibitory activity
of aqueous extract of O. gratissmum on acetylcholin-
esterase (AChE) enzyme. AChE activity was inhibited
by aqueous extract of O. gratissmum as the concen-
tration increases. Hence, aqueous extract of O. gra-
tissmum had a better inhibitory activity on penile
AChE activity (IC50 = 55.51 μg/mL) than testicular
AChE activity (IC50 = 60.03 μg/mL) as shown by their
IC50 values listed in Table 1.
Figure 4 revealed the inhibition of ACE activity by
aqueous extract of O. gratissmum in penile and testicular
tissue homogenates. ACE activity was inhibited by both
the aqueous extract of O. gratissmum and lisinopril.
However, aqueous extract of O. gratissmum had a better
Fig. 1 Inhibition of Phosphodiesterase-5 activity in rats’ genitals by aqueous extract from Ocimum gratissimum leaves
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inhibitory activity on penile than testicular ACE activity
as shown by their IC50 values listed in Table 1.
Figure 5 revealed the ferric reducing ability of the ex-
tract. The result revealed that the extracts inhibited fer-
ric reducing power in a concentration-dependent
manner. However, vitamin C was able to reduce the Fe3+
to Fe2+ better than the O. gratissimum extract as re-
vealed by their IC50 values in Table 1.
Fig. 6 revealed the ability of the leaf aqueous extract of
O. gratissmum to scavenge DPPH. in penile and testicu-
lar tissues. Aqueous extract of O. gratissmum was able
to scavenge DPPH.. However, vitamin C scavenge DPPH*
better than the O. gratissimum extract as revealed by
their IC50 values in Table 1.
Discussion
The mechanisms or actions of cGMP are mainly de-
creased by the phosphodiesterase-5 enzyme in diverse
parts of corpus cavernosum [5]. PDE-5, an important
enzyme of the NO/cGMP signaling pathway, that per-
forms a key function in corpus cavernosum weakness,
inhibition of nitric oxide-induced cGMP-mediated vaso-
dilation and repairing basal smooth muscle tone and
penile detumescence. Thus, the rate of synthesis of
cGMP by guanylate cyclase and its degradation by PDEs
determines the amount of cGMP within the corpus
cavernosum [5]. A protein kinase that decreases cytosolic
calcium levels, boosts smooth muscle relaxation leading
to penile erection is activated by cGMP [37, 38]. Sildenafil,
Table 1 IC50 values (μg/mL) of ferric reducing power, DPPH, PDE-5, arginase, ACE and AChE inhibitory activities in rat penile and
testicular tissue by O. gratissimum leaf extracts and standard drugs/inhibitors
Sample PDE-5 (μg/mL) Arginase (μg/mL) ACE (μg/mL) AChE (μg/mL) FRAP (μg/mL) DPPH (μg/mL)
Penis 43.19 ± 0.02c 46.12 ± 0.15c 44.23 ± 0.71a 55.51 ± 0.45a – –
Testes 44.67 ± 0.01b 49.12 ± 0.12b 53.99 ± 0.85a 60.03 ± 0.34a – –
Sildenafil (μg/mL) 26.65 ± 0.10a – – – – –
L-NOHA (μg/mL) – 42.48 ± 0.21a – – – –
Lisinopril (μg/mL) – – 38.34 ± 0.01a – – –
Prostigmine (μg/mL) – – – 48.01 ± 1.02a – –
Vitamin C (μg/mL) – – – – 46.16 ± 0.51a 53.81 ± 0.02a
O. gratissimum extract – – – – 56.55 ± 0.78a 69.41 ± 0.01a
Values represent mean ± standard deviation (n = 3). Values with the same superscript along the column are not significant (p < 0.05) different. Sildenafil*: standard
drug for phosphodiesterase-5 (PDE-5); L-NOHA*: standard inhibitor for arginase; prostigmine*: standard drugs for AChE; Lisinopril*: standard drug for ACE; Vitamin
C*: standard drug for ferric reducing power (FRAP) and DPPH
Fig. 2 Inhibition of Arginase activity in rats’ genitals by aqueous extract from Ocimum gratissimum leaves
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tadalafil, and vardanafil which are PDE-5 inhibitors do not
only boost the level of cGMP [39, 40] but, likewise, stimu-
late its activation resulting in the increase of NO leading
to the penile erection. However, these PDE-5 inhibitor
drugs have other negative effects such as nasal congestion,
headache, visual aberrations’ dyspepsia, [41]. Furthermore,
previous studies have shown that phenolic compounds in
plant exhibit PDE-5 inhibition [6, 42, 43]. Hence, the
result showed that the extract inhibited PDE-5 activity,
this may be due to the presence of phenolic compounds
particularly flavonoids, that functions as an endothelium-
independent relaxer [33, 44].
Several studies have previously revealed that nitric
oxide production is associated with arginase activity
regulation [45]. Current examinations have acknowl-
edged arginase in managing sexual disorders [46, 47]
leading to upregulation of arginase activity and reduced
nitric oxide levels in the penile tissues. In ED, reduced
NO are documented owing to improved arginase activ-
ities and changed the expression of endothelial NO syn-
thase (eNOS) [48]. Nevertheless, it is important to note
that arginase inhibition by the O. gratissimum extracts
may possibly be an alternative route of increasing the
appearance and activities of eNOS, thus raising the
Fig. 3 Inhibition of Acetylcholinesterase activity in rats’ genitals by aqueous extract from Ocimum gratissimum leaves
Fig. 4 Inhibition of Angiotensin-I-converting enzyme activity in rats’ genitals by aqueous extract from Ocimum gratissimum leaves
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bioavailability of nitric oxide. Therefore, the ability of
the extract to inhibit an arginase could be due to the
presence of phenolics with arginase inhibitory properties
which is supported by previous studies [8, 14, 49]. Our
findings showed that aqueous extract from O. gratissi-
mum inhibited arginase activity. Hence, the inhibitory
activity observed could be linked to the presence of fla-
vonoids and phenolic compounds like (−)-rutin, kaemp-
ferol, rosmarinic acid, caffeic acid and cichoric acid
present in O. gratissimum extract reported by [50].
Moreover, Da Silva et al. [51] showed that flavonoids
such as rutin are strong inhibitors of arginase enzyme.
Numerous studies have documented that cholinergic
nerves in penile tissues must be able to release acetyl-
choline for the activation of NO production from
L-arginine by nitric oxide synthase for better erectile
function [7, 52–54]. The inhibition of the enzyme in
penile and testicular tissue homogenates suggests that O.
gratissimum could be a promising plant with beneficial
potentials for the management of ED. Thus, inhibition
of AChE by the extracts could be linked to the presence
of flavonoids and phenolic compounds, which correlates
with earlier studies that phenolic-rich plants could in-
hibit AChE [8, 9, 55, 56].
Angiotensin-II has been associated with hypertension
a key causative agent of erectile dysfunction [8, 57].
Hence, the inhibition of ACE leading to the prevention
of angiotensin- II synthesis may be a remedial target in
the management of ED. Jin [58] documented that the
Fig. 5 DPPH radical scavenging ability of aqueous extract of O. gratissimum leaves and vitamin C
Fig. 6 Ferric reducing antioxidant property (FRAP) of aqueous
extract of O. gratissimum leaves and vitamin C
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considerable increase in NADPH oxidase activity, pro-
duction of ROS and inhibition of nitric oxide synthase
activity in penile and testicular tissues may be possible
due to the elevated levels of angiotensin-II. Thus, hin-
dering the production of angiotensin II could be helpful
in the treatment of ED. Hence, these interactions could
be due to the phenolic and flavonoids present in the
leaves and disulphide bridge of the enzyme [57, 59, 60].
Moreover, flavonoids and phenols such as rutin, kaemp-
ferol, cichoric acid and caffeic acid present in the plant
have been reported to be strong inhibitors of ACE activ-
ity [61, 62], and may be accounted for the greater inhibi-
tory effect displayed by O. gratissimum. Thus, this study
showed that aqueous extract from O. gratissimum inhib-
ited ACE activity, reducing angiotensin II levels in erec-
tion organs.
Antioxidants achieve their protective role mainly by hin-
dering the generation of radicals or by scavenging radical’s
production [21, 23, 63]. The mechanism of actions ac-
knowledged influencing ferric reducing power as an anti-
oxidant system is via proton transfer and electron transfer
[21, 23, 64]. The reducing capacity of the extracts could
also indicate potential antioxidant activities [65]. This re-
ducing property could be because of the presence of poly-
phenols. Reducing power of O. gratissimum might have a
therapeutic effect on erectile dysfunction.
In this study, O. gratissimum at the concentration
tested revealed considerably ability to act as radical scav-
engers. This study revealed that aqueous extracts of O.
gratissimum scavenged free radicals. The greater scaven-
ging ability of the O. gratissimum may be accredited to
the presence of secondary metabolites like phenolic
acids and flavonoids [66]. All these radicals are involved
in the pathogenesis of several disorders including erect-
ile dysfunction. Hence, findings from this investigation
shown that O. gratissimum extracts possessed antioxi-
dant activity having reasonable scavenging activity to-
wards the various forms of radicals studied [67, 68].
Conclusion
This study revealed that O. gratissimum extracts exhib-
ited inhibitory properties on enzyme activities involved
in erectile function and displayed free radical scavenging
abilities which might be connected to their phenolic and
flavonoids components. This indicates the erection
stimulating properties of the plants and possible reasons
for its use in the management of erectile dysfunction.
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